Bioheart Inc previously announced that it is working with NorthStar Biotech to help promote regenerative medicine. NorthStar has announced that it will subsidize physicians to participate in the Ageless Regenerative Institute stem cell training program. The fully accredited CME training program includes a didactic lecture series followed by hands-on clinical training for physicians to learn to isolate stem cells for immediate use in their patients. The Ageless Regenerative Institute has successfully trained over 200 physicians and these physicians are utilizing both adipose and bone marrow derived stem cells as well as platelet rich plasma for orthopedics, aesthetics and other degenerative diseases.
With the new NorthStar/Bioheart program, this select group of physicians have the opportunity to receive full funding for the training and join a network of physicians who will offer in-clinic stem cell therapies. Once these physicians commence IRB-approved in-clinic services, Bioheart will receive royalties for the use of these fee-for-service procedures. Initial projections have not been announced by NorthStar.
“Physicians have for years evaluated and considered stem cell treatments as a potential alternative for a subset of our patient population. This program helps educate doctors and allows us a viable opportunity to expand our treatment portfolio for patients in need,” said board-certified Miami internist Dr. Antonio Blanco.
Bioheart’s president and CEO Mike Tomas said, “The training programs at the Ageless Regenerative Institute provide physicians with extraordinary regenerative medicine capabilities. We are fortunate to partner with Northstar to bring these therapies to the clinic.”